These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20368576)

  • 1. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.
    Moody MA; Liao HX; Alam SM; Scearce RM; Plonk MK; Kozink DM; Drinker MS; Zhang R; Xia SM; Sutherland LL; Tomaras GD; Giles IP; Kappes JC; Ochsenbauer-Jambor C; Edmonds TG; Soares M; Barbero G; Forthal DN; Landucci G; Chang C; King SW; Kavlie A; Denny TN; Hwang KK; Chen PP; Thorpe PE; Montefiori DC; Haynes BF
    J Exp Med; 2010 Apr; 207(4):763-76. PubMed ID: 20368576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
    Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
    Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
    Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes.
    Babaahmady K; Bergmeier LA; Whittall T; Singh M; Wang Y; Lehner T
    J Immunol Methods; 2002 Jun; 264(1-2):1-10. PubMed ID: 12191503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.
    Bégaud E; Chartier L; Marechal V; Ipero J; Léal J; Versmisse P; Breton G; Fontanet A; Capoulade-Metay C; Fleury H; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Jun; 3():35. PubMed ID: 16792805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flagellin Restricts HIV-1 Infection of Macrophages through Modulation of Viral Entry Receptors and CC Chemokines.
    Zhou L; Wang X; Xiao Q; Khan S; Ho WZ
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
    Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus.
    Zaitseva M; King LR; Manischewitz J; Dougan M; Stevan L; Golding H; Golding B
    Infect Immun; 2001 Jun; 69(6):3817-26. PubMed ID: 11349047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-C motif chemokine ligand (CCL) production in equine peripheral blood mononuclear cells identified by newly generated monoclonal antibodies.
    Schnabel CL; Wemette M; Babasyan S; Freer H; Baldwin C; Wagner B
    Vet Immunol Immunopathol; 2018 Oct; 204():28-39. PubMed ID: 30596378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
    Lehner T; Wang Y; Cranage M; Tao L; Mitchell E; Bravery C; Doyle C; Pratt K; Hall G; Dennis M; Villinger L; Bergmeier L
    Immunology; 2000 Apr; 99(4):569-77. PubMed ID: 10792505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.